S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The Ignored EV Story Few Investors Know About (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
The Ignored EV Story Few Investors Know About (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The Ignored EV Story Few Investors Know About (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
The Ignored EV Story Few Investors Know About (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The Ignored EV Story Few Investors Know About (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
The Ignored EV Story Few Investors Know About (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
Soaring EV Industry Keeps Investor Focus on Lithium (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The Ignored EV Story Few Investors Know About (Ad)
Dollar General May Create an Opportunity for Patient Investors
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
The Ignored EV Story Few Investors Know About (Ad)
SunCar Technology Stock Overheats...Will it Rise Again?
How major US stock indexes fared Monday 6/5/2023
NASDAQ:INZY

Inozyme Pharma (INZY) Earnings Date, Estimates & Call Transcripts

$6.31
-0.12 (-1.87%)
(As of 06/5/2023 ET)
Compare
Today's Range
$6.20
$6.77
50-Day Range
$4.37
$6.74
52-Week Range
$0.99
$7.24
Volume
436,921 shs
Average Volume
561,715 shs
Market Capitalization
$277.83 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.00

Earnings Summary

Upcoming
Earnings Date
Aug. 21Estimated
Actual EPS
(Mar. 22)
-$0.42 Beat By $0.04
Consensus EPS
(Mar. 22)
-$0.46
Last Year's Q1 EPS
(3/15/2022)
-$0.79
Skip Charts & View Estimated and Actual Earnings Data

INZY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

INZY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Inozyme Pharma Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20233($0.66)($0.40)($0.50)
Q2 20234($0.68)($0.39)($0.49)
Q3 20234($0.72)($0.31)($0.49)
Q4 20234($0.68)($0.34)($0.51)
FY 202315($2.74)($1.44)($1.98)

INZY Earnings Date and Information

Inozyme Pharma last issued its earnings results on March 22nd, 2023. The reported ($0.42) EPS for the quarter, beating analysts' consensus estimates of ($0.46) by $0.04. Inozyme Pharma has generated ($1.58) earnings per share over the last year (($1.58) diluted earnings per share). Earnings for Inozyme Pharma are expected to grow in the coming year, from ($1.70) to ($1.67) per share. Inozyme Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off prior year's report dates.

Inozyme Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/21/2023
(Estimated)
        
5/9/2023Q1 2023($0.44)($0.40)+$0.04($0.40)
3/22/2023Q4 2022($0.46)($0.42)+$0.04($0.42)
11/10/2022Q3 2022($0.43)($0.38)+$0.05($0.38)
8/15/2022Q2 2022($0.48)($0.38)+$0.10($0.38)
5/10/2022Q1 2022($0.81)($0.71)+$0.10($0.71)    
3/15/2022Q4 2021($0.73)($0.79)($0.06)($0.79)
11/9/20219/30/2021($0.61)($0.60)+$0.01($0.60)
8/11/20216/30/2021($0.57)($0.53)+$0.04($0.53)
5/12/2021Q1($0.5420)($0.47)+$0.0720($0.47)
3/24/202112/31/2020($0.55)($1.01)($0.46)
11/12/20209/30/2020($0.51)($1.55)($1.04)($1.55)
9/3/2020Q2($1.4130)($7.57)($6.1570)($7.57)












Inozyme Pharma Earnings - Frequently Asked Questions

When is Inozyme Pharma's earnings date?

Inozyme Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 21st, 2023 based off last year's report dates. Learn more on INZY's earnings history.

Did Inozyme Pharma beat their earnings estimates last quarter?

In the previous quarter, Inozyme Pharma (NASDAQ:INZY) reported ($0.42) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.04. Learn more on analysts' earnings estimate vs. INZY's actual earnings.

How much profit does Inozyme Pharma generate each year?

Inozyme Pharma (NASDAQ:INZY) has a recorded net income of -$67.06 million. INZY has generated -$1.58 earnings per share over the last four quarters.

What is Inozyme Pharma's EPS forecast for next year?

Inozyme Pharma's earnings are expected to grow from ($1.70) per share to ($1.67) per share in the next year.

More Earnings Resources from MarketBeat

This page (NASDAQ:INZY) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -